People with obesity have long struggled to control their weight, and new medications, including semaglutide and others, have been game changers for many, said Colin Banas, M.D., M.H.A., chief medical officer for DrFirst
Research shows this side effect impacts 3% of adult users
Its Not Recommended by Either the FDA or the Drug Maker Both the US Food and Drug Administration (FDA) and Novo Nordisk, the maker of Wegovy and Ozempic, have warned against splitting semaglutide doses exactly for the reasons weve outlined above: its not sterile, it introduces too much room for error, and it can increase the risk of side effects
At Batley Pharmacy, we see these injections as a tool to quiet the food noise and help you build sustainable habits that will last long after you finish the medication
"But they're completely out of Zepbound, 15 milligram and 10 milligram, Mounjaro 10 milligramThere's no allocation, zero availability to order any of it." Compounders strike back On Oct